Clinical trials
Phase 1/2 Carcinoma, Renal Cell trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
147 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 4 |
| 2001 | 3 |
| 2002 | 3 |
| 2003 | 1 |
| 2004 | 3 |
| 2005 | 6 |
| 2006 | 5 |
| 2007 | 2 |
| 2008 | 3 |
| 2009 | 3 |
| 2010 | 5 |
| 2011 | 1 |
| 2012 | 4 |
| 2013 | 2 |
| 2014 | 4 |
| 2015 | 8 |
| 2016 | 9 |
| 2017 | 12 |
| 2018 | 8 |
| 2019 | 7 |
| 2020 | 6 |
| 2021 | 12 |
| 2022 | 5 |
| 2023 | 8 |
| 2024 | 7 |
| 2025 | 6 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 59 |
| Terminated | 32 |
| Recruiting | 30 |
| Active, not recruiting | 17 |
| Unknown status | 4 |
| Withdrawn | 3 |
| Suspended | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 15 |
| Incyte Biosciences International Sàrl | 5 |
| M.D. Anderson Cancer Center | 5 |
| Memorial Sloan Kettering Cancer Center | 5 |
| Fred Hutchinson Cancer Center | 4 |
| Merck Sharp & Dohme LLC | 4 |
| Bristol-Myers Squibb | 3 |
| Regeneron Pharmaceuticals | 3 |
| Argos Therapeutics | 2 |
| Calithera Biosciences, Inc | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Renal Cell | 147 |
| Carcinoma, Non-Small-Cell Lung | 45 |
| Melanoma | 39 |
| Kidney Neoplasms | 31 |
| Squamous Cell Carcinoma of Head and Neck | 24 |
| Neoplasm Metastasis | 20 |
| Colorectal Neoplasms | 19 |
| Stomach Neoplasms | 17 |
| Triple Negative Breast Neoplasms | 17 |
| Uterine Cervical Neoplasms | 16 |
Trials
Showing 1 to 25 of 147. Each trial links to its page on Pharma Observatory.
47 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.